Management Consulting

Portfolio Management

Financial solutions tailored to your business goals

Benefit from customized solutions aimed at optimizing returns and managing risks through asset prioritization and diversification in adjacent markets with Alira Health Portfolio Management.

A proprietary methodology backed by experience

Many of our clients structure their company around a specific platform to develop many assets in very different markets. And while spreading risk over several assets is always positive, as companies face resource shortages, they need to focus on a limited number of opportunities with increased probabilities of success to convince investors.

To meet those needs, Alira Health has developed a proprietary methodology and associated tools to allow our clients to prioritize assets and define an investment strategy that ensures operational success and value creation.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • An integrated team with experience across the product lifecycle
  • Proprietary digital tools tailored to your business needs
  • Click here to see our approach in action for a leading pharmaceutical company

Related news

MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
Pharma
News December 15, 2020
Welcome Daniela Sica, Vice President, Business Development, Pharma and Biotech
We are pleased to announce that Daniela Sica has joined the firm as Vice President, Business Development, Pharma and Biotech.
Market Access Pharma
Publications November 2, 2020
WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden(...)
Advanced Analytics Market Access Pharma
Publications November 1, 2020
Our Parallel Trade Expertise
Alira Health is proud to announce our new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.
Pharma
Publications August 1, 2020
Pre-Commercial Value Assessment of a Nuclear Medicine Pair to Diagnose and Treat Neuroendocrine Tumors (NET)
When our client, a leading radiopharmaceutical company, needed support to understand the commercial opportunity represented by a Phase III radiopharmaceutical and its diagnostic radiotracer(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.